Back

Capricor investors face Sept. 28 lead plaintiff deadline after FDA review extension

Verifying
  • Hagens Berman notified Capricor investors about the securities lawsuit's lead plaintiff deadline.
  • Sept. 28, 2026, is the deadline to seek appointment as lead plaintiff.
  • FDA documents preceded a 9-3 Advisory Committee vote against deramiocel's efficacy.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Capricor investors face Sept. 28 lead plaintiff deadline after FDA review extension - CoinPost Terminal